Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Frank R. Ernst, Peri Barr, Riad Elmor & Schiffon L. Wong. (2017) Relapse outcomes, safety, and treatment patterns in patients diagnosed with relapsing-remitting multiple sclerosis and initiated on subcutaneous interferon β-1a or dimethyl fumarate: a real-world study. Current Medical Research and Opinion 33:12, pages 2099-2106.
Read now
Read now
Dominic Pilon, Tony B. Amos, Guillaume Germain, Marie-Hélène Lafeuille, Patrick Lefebvre & Carmela J. Benson. (2017) Treatment persistence and hospitalization rates among patients with schizophrenia: a quasi-experiment to evaluate a patient information program. Current Medical Research and Opinion 33:4, pages 713-721.
Read now
Read now
Articles from other publishers (7)
Michael Lang, Lukas Cepek, Daniela Rau, Nadine Denkinger, Katja Behrens & Anselm Kornhuber. (2022) Steigerung der Therapietreue durch niederschwellige Kontakte. Nervenheilkunde 41:07/08, pages 497-501.
Crossref
Crossref
Chiara Zecca, Adam Czaplinski, Christophe Henny, Liliane Petrini, Andreas Beeler & Claudio Gobbi. (2020) SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting. Heliyon 6:12, pages e05819.
Crossref
Crossref
Florian Lenz & Lutz Harms. (2020) The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective Study. Advances in Therapy 37:6, pages 2999-3009.
Crossref
Crossref
Almudena Buesa-Estelléz, Roberto Cano-de-la-Cuerda, Rosa María Ortiz-Gutiérrez & Domingo Palacios-Ceña. (2019) The impact of pharmacological treatment on patients with multiple sclerosis. Disability and Health Journal 12:4, pages 615-621.
Crossref
Crossref
Peter Rieckmann, Matthias Schwab, Dieter Pöhlau, Iris-Katharina Penner, Torsten Wagner, Elke Schel & Antonios Bayas. (2018) Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis: Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart®. Advances in Therapy 36:1, pages 175-186.
Crossref
Crossref
Martin Marziniak, Giampaolo Brichetto, Peter Feys, Uta Meyding-Lamadé, Karen Vernon & Sven G Meuth. (2018) The Use of Digital and Remote Communication Technologies as a Tool for Multiple Sclerosis Management: Narrative Review. JMIR Rehabilitation and Assistive Technologies 5:1, pages e5.
Crossref
Crossref
Charity Evans, Ruth Ann Marrie, Feng Zhu, Stella Leung, Xinya Lu, Dessalegn Y. Melesse, Elaine Kingwell, Yinshan Zhao & Helen Tremlett. (2016) Adherence and persistence to drug therapies for multiple sclerosis: A population-based study. Multiple Sclerosis and Related Disorders 8, pages 78-85.
Crossref
Crossref